greeksoup/ stock research

Entegris Inc.: Q2 FY2026 earnings call

What management said about Q2 FY2026, from the documents filed with the SEC on 4 August 2026: press release. Guidance figures: 13 new. The quarter’s numbers.

Key takeaways

  • Sales rose on unit and capex demand: Net sales were $883.2 million, up from $792.4 million a year earlier. Management tied the growth to unit and capex-related businesses. Source
  • Per-share earnings rose on both bases: GAAP diluted EPS was $0.61 against $0.35, with net income of $93.6 million against $52.8 million. Non-GAAP diluted EPS was $0.93 against $0.66. Source
  • Advanced Purity sales and profit rose: APS net sales were $514.6 million against $439.9 million. Segment profit was $150.9 million against $95.9 million, and adjusted segment profit was $155.8 million against $105.8 million. Source
  • Adjusted operating margin rose: Adjusted operating margin was 24.5% of net sales against 20.9%. Adjusted operating income was $216.3 million against $165.4 million. Source
  • Adjusted EBITDA margin rose: Adjusted EBITDA was $250.7 million, or 28.4% of net sales, against $216.7 million and 27.3% a year earlier. Source
  • Operating cash flow rose: Operating cash flow was $156.2 million against $113.5 million, and $339.2 million for the six months against $253.9 million. Source
  • Third-quarter ranges issued: Ranges for sales, GAAP and non-GAAP diluted EPS, net income and Adjusted EBITDA margin were issued for the quarter ending September 26, 2026. Source

“exceeding our guidance across all key metrics as improving semiconductor demand and accelerating customer capital investments drove double-digit growth across both our unit and capex-related businesses.”

Dave Reeder, Entegris’ President and Chief Executive Officer

Guidance

AreaPeriodFigureAgainst last quarter
Net sales SourceQ3 2026 (quarter ending September 26, 2026)$905 million to $935 millionNew
GAAP net income SourceQ3 2026 (quarter ending September 26, 2026)$116 million to $128 millionNew
GAAP diluted EPS SourceQ3 2026 (quarter ending September 26, 2026)$0.75 to $0.83New
Non-GAAP net income SourceQ3 2026 (quarter ending September 26, 2026)$148 million to $160 millionNew
Non-GAAP diluted EPS SourceQ3 2026 (quarter ending September 26, 2026)$0.96 to $1.04New
Adjusted EBITDA margin SourceQ3 2026 (quarter ending September 26, 2026)approximately 28.0% to 29.0% of salesNew
GAAP operating income SourceQ3 2026 (quarter ending September 26, 2026)$174 million to $189 million (19.2% to 20.2% of net sales)New
Adjusted operating income SourceQ3 2026 (quarter ending September 26, 2026)$219 million to $234 million (24.2% to 25.1% of net sales)New
Adjusted EBITDA SourceQ3 2026 (quarter ending September 26, 2026)$253 million to $269 millionNew
Amortization of intangible assets SourceQ3 2026 (quarter ending September 26, 2026)$45 millionNew
Depreciation SourceQ3 2026 (quarter ending September 26, 2026)$34 millionNew
Income tax effect in non-GAAP net income SourceQ3 2026 (quarter ending September 26, 2026)(13) millionNew
Per-share adjustments to GAAP EPS SourceQ3 2026 (quarter ending September 26, 2026)0.29 amortization; (0.08) income tax effectNew

What changed from last quarter

  • New guidance: Guidance for the quarter ending September 26, 2026 is given here; the April release gave guidance only for the second quarter. Source
  • New: The restructuring footnote now names the wind-down of the Life Sciences Fluid Management business, which the April release did not list. Source

Second-quarter results and growth

  • Sales rose on unit and capex demand: Net sales were $883.2 million, up from $792.4 million a year earlier. Management tied the growth to unit and capex-related businesses. Source
  • Per-share earnings rose on both bases: GAAP diluted EPS was $0.61 against $0.35, with net income of $93.6 million against $52.8 million. Non-GAAP diluted EPS was $0.93 against $0.66. Source
  • Operating income rose: Operating income was $164.6 million against $106.1 million a year earlier, with income before income tax expense of $110.1 million against $55.8 million. Source
  • Six-month sales and diluted EPS rose: For the six months, net sales were $1,695.1 million against $1,565.6 million, and diluted EPS was $1.21 against $0.76. Source

Segment results

  • Advanced Purity sales and profit rose: APS net sales were $514.6 million against $439.9 million. Segment profit was $150.9 million against $95.9 million, and adjusted segment profit was $155.8 million against $105.8 million. Source
  • Materials Solutions sales and profit rose: MS net sales were $371.3 million against $354.9 million. Segment profit was $77.7 million against $72.5 million, and adjusted segment profit was $77.7 million against $75.5 million. Source
  • Unallocated costs rose: Unallocated general and administrative expenses were $17.9 million against $16.3 million, or $17.2 million against $15.9 million after restructuring adjustments. Source

“The next phase of semiconductor investment is underway, and with market-leading positions across our portfolio, growing participation at the industry's most advanced technology nodes”

Dave Reeder, Entegris’ President and Chief Executive Officer

Margins and operating costs

  • Gross margin rose: GAAP gross margin was 47.6% of net sales against 44.4% a year earlier, and adjusted gross margin was 47.6% against 44.6%. Source
  • Adjusted operating margin rose: Adjusted operating margin was 24.5% of net sales against 20.9%. Adjusted operating income was $216.3 million against $165.4 million. Source
  • Adjusted EBITDA margin rose: Adjusted EBITDA was $250.7 million, or 28.4% of net sales, against $216.7 million and 27.3% a year earlier. Source
  • SG&A rose while R&D fell: Selling, general and administrative expenses were $126.5 million against $115.1 million. Engineering, research and development expenses were $82.8 million against $84.3 million. Source
  • Depreciation fell: Depreciation was $34.4 million against $51.3 million a year earlier. Amortization of intangibles was $46.1 million against $46.0 million. Source

Cash flow, balance sheet and capital

  • Operating cash flow rose: Operating cash flow was $156.2 million against $113.5 million, and $339.2 million for the six months against $253.9 million. Source
  • Capital spending was lower: Capital expenditure was $39.3 million against $66.5 million, and $80.8 million for the six months against $174.5 million. Government incentive proceeds were $3.4 million. Source
  • Debt repayments in the quarter: Debt payments were $200.0 million in the quarter, with no new borrowing. Six-month payments were $315.0 million, against $65.0 million of proceeds. Source
  • Cash and long-term debt declined: Cash was $353.6 million against $360.4 million at December 31, 2025. Long-term debt was $3,456.0 million against $3,697.6 million. Source
  • Receivables and inventory increased: Trade receivables were $559.1 million against $458.7 million at December 31, 2025, and inventories were $703.9 million against $643.2 million. Source
  • Dividend payments held near prior level: Dividend payments were $15.4 million, against $15.2 million a year earlier. Common stock issuance proceeds were $18.2 million against $0.1 million. Source

“Our operational initiatives continued to enhance profitability and cash generation, further strengthening our financial position.”

Dave Reeder, Entegris’ President and Chief Executive Officer

Third-quarter guidance

  • Third-quarter ranges issued: Ranges for sales, GAAP and non-GAAP diluted EPS, net income and Adjusted EBITDA margin were issued for the quarter ending September 26, 2026. Source
  • Non-GAAP bridge adds back amortization: The non-GAAP bridge adds back amortization of intangibles and depreciation to reach adjusted operating income and Adjusted EBITDA, with an income tax effect. Source
  • Reconciliation tables may show rounding: The release states that amounts are displayed in millions, so rounding differences may appear in the reconciliation tables. Source

Restructuring, other items and interest

  • Restructuring costs fell: Restructuring costs were $5.6 million against $13.3 million, tied mainly to an internal reorganization combining two divisions and to workforce reductions. Source
  • Equity impairment and debt extinguishment loss: A $6.7 million equity investment impairment was excluded from non-GAAP results. A $1.7 million loss on extinguishment of the Term Loan Facility was also recorded. Source
  • Interest and tax expense: Net interest expense was $46.7 million against $50.5 million, and income tax expense was $16.5 million against $2.8 million. Source

Business profile and reporting

  • Segment product scope: APS covers filtration, purification and contamination control. MS covers deposition, planarization, ion implantation, etch and clean materials. Source
  • About 7,700 employees: Entegris reported about 7,700 employees across its global operations, with facilities in ten countries. Source
  • Non-GAAP measures used internally: Management uses non-GAAP measures to evaluate segment performance and make operating decisions. Source

Coming up, as management said on 4 August 2026

  • Slide presentation to be posted: Management said its slide presentation on the second-quarter results would be posted to the investor relations section of the website. Source

Earlier plans management reported on

  • Ahead: Management said results exceeded second-quarter guidance on all key metrics. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.